Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Marksans Pharma Limited
No Price
Closing Price XNSE 29.04.2026:
187,76 INR
29.04.2026 10:18
Current Prices from Marksans Pharma Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
MSE
MARKSANS.BO
INR
29.04.2026 10:18
187,55 INR
3,00 INR
+1,63 %
NSE
MARKSANS.NS
INR
29.04.2026 10:00
187,76 INR
3,21 INR
+1,74 %
Share Float & Liquidity
Free Float47,28 %
Shares Float214,28 M
Shares Outstanding453,16 M
Company Profile for Marksans Pharma Limited Share
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
